Oric Pharmaceuticals, Inc. (ORIC)
13.26
-0.25
(-1.85%)
USD |
NASDAQ |
Mar 05, 13:27
Oric Pharmaceuticals Research and Development Expense (Annual) : 109.82M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Johnson & Johnson | 14.83B |
| Pfizer Inc. | 10.25B |
| Krystal Biotech, Inc. | 52.32M |
| Olema Pharmaceuticals, Inc. | 124.52M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |